[1]Naalweh KS,Barakat MA,Sweileh MW,et al.Treatment adherence and perception in patients on maintenance hemodialysis:a cross-sectional study from Palestine[J].Bmc Nephrol,2017,18(1):178.
[2]Woo KT,Choong HL,Wong KS,et al.The contribution of chronic kidney disease to the global burden of major noncommunicable disease[J].Kidney Int,2012,81(10):1044-1045.
[3]Hao YH,Jiang YF.Symptom experiences among maintenance hemodialysis patients:a cross-sectional study.J Nurs,2016,51(3):299-303．
[4]Tang Y,Purkayastha S,Cai D.Hypothalamic microninflammation:a common basis of metabolic syndrome and aging[J].Trends
Neurosci,2015,38(1):36-44.
[5]李红微,刘云霞.不同血液净化方式对尿毒症患者血清C反应蛋白、白介素-6、血红蛋白及血浆白蛋白水平的影响[J].中国当代医药,2016,23(1):71-73.
[6]Beberashvili I,Sinuani I,Azar A,et al.Serumuric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients[J].Nutrition,2015,31(1):138-147.
[7]Benz K,Hilgers KF,Daniel C,Amann K.Vascular Calcification in Chronic Kidney Disease:The Role of Inflammation.Int J Nephrol.2018,2018:4310379.
[8]Allawi AAD.Malnutrition,inflamation and atherosclerosis (MIA syndrome) in patients with end stage renal disease on maintenance hemodialysis(a single centre experience).Diabetes Metab Syndr.2018,12(2):91-97.
[9]Kim SJ,Lee YK,Oh J,Cho A,Noh JW.Effects of low calcium dialysate on the progression of coronary artery calcification in hemodialysis patients: An open-label 12-month randomized clinical trial.International journal of cardiology.2017,243:431-6.
[10]Jean G,Mayor B,Deleaval P,Lorriaux C,Hurot JM,Bresson E,et al.Vascular Calcification Progression Is an Independent Predictor of Mortality in Patients on Haemodialysis.Nephron.2015,130(3):169-74.
[11]Choi SR,Lee YK,Cho AJ, et al.Malnutrition,inflammation,progression of vascular calcification and survival:Inter-relationships in hemodialysis patients.PLoS One.2019,14(5):e0216415.
[12]El Sewefy DA,Farweez BA,Behairy MA,Yassin NR.Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients.Int Urol Nephrol. 2019,51(2):325-334.?
[13]Tian J,Hou X,Hu L,et al.Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients.Ren Fail.2017,39(1):153-158.
[14]Halle MP,Zebaze PN,Mbofung CM,et al.Nutritional status of patients on maintenance hemodialysis in urban sub-Saharan Africa:evidence from Cameroon[J].J Nephrol,2014,27(5):545-553．
[15]李秋歌,黄佳佳,宗娟娟.骨化三醇胶丸对维持性血液透析患者微炎症状态及钙磷代谢的影响分析[J].首都食品与医药,2020,27(03):97.
[16]血液净化模式选择专家共识[J].中国血液净化,2019,18(07):442-472.
[17]张培光.高通量血液透析对尿毒症患者毒素清除效果及微炎症状态的影响[J].黑龙江医药,2020,33(02):399-401.
[18]盛丹虹,齐玲.不同透析方式对血液透析患者炎性因子、内皮功能的影响[J].中国医药导报,2020,17(05):71-74.
[19]陈铭,张应宏.高通量血液透析治疗尿毒症的疗效及预后分析[J].解放军预防医学杂志,2019,37(05):119-120.
[20]邓莉莉,胡爽,尹娜, 等.两种透析方法对尿毒症患者微炎症状态及毒素清除的疗效比较[J].检验医学与临床,2019,16(11):1573-1575.
[21]G.F.Schiavano,L.Parlani,M.Sisti,et al.Occurrence of fungi in dialysis water and dialysate from eight haemodialysis units in central Italy[J].J Hosp Infect,2014,(86):194-200.
[22]Schindler R,Beck W,Deppsich R,et al.Short bacterial DNA fragments: detection in dialysate and induction of cytokines[J].J Am
Soc Nephrol,2004,15(12):3207-3214．
[23]Bossola M,Sanguinetti M,Scribano D,et al.Circulating bacterial derived DNA fragments and markers of inflammation in chronic he
modialysis patients[J].Clin J Am Soc Nephrol,2009,4(2):379-385．
[24]徐新伟,尹芳,赵战云,等.超纯透析液对血液透析患者外周血炎性细胞因子及血管硬化水平的影响[J].国际检验医学杂志,2019,40(5):561-564.
[25]Anonymous NKF-DOQI.clinical practice guidlines for vascular access National kidney Foundation-Dialysis outcomes Quality Initiative[J].Am J Kidney Dis,1997,30(l13):150.
[26]Mala Sachdeva,Adriana Hung,Oleksandr Kovalchuk,et al.The Initial Vascular Access Type Contributes to Inflammation in Incident Hemodialysis Patients[J].International Journal of Nephrology,2011,2012.
[27]李隽,李海燕.动静脉内瘘和透析导管对老年透析患者透析充分性、微炎症状态和肾性贫血的影响[J].中国中西医结合肾病杂志,2020,21(02):148-150.
[28]高良云,胡日红,姚国明,王利峰,朱星瑜.不同频率血液透析滤过对维持性血液透析患者促红细胞生成素疗效的影响[J].中国中西医结合肾病杂志,2020,21(02):123-126.
[29]Chandrashekar A,Ramakrishnan S,Rangarajan D.Survival analysis of patients on maintenance hemodialysis[J].Indian J Nephrol,2014,24(4):206-213.
[30]何联义.不同透析频率在尿毒症血液透析患者中的应用效果[J].临床荟萃,2015,30(11):1292-1296.
[31]Abe M,Hamano T,Wada A,Nakai S,Masakane I,Renal Data Registry Committee JSfDT.Effect of dialyzer membrane materials on survival in chronic hemodialysis patients:results from the annual survey of the Japanese Nationwide Dialysis Registry.PLoS One.2017,12:e0184424.
[32]Kohlova,Michaela.Amorim.Celia Gomes,Araujo,Alberto,et al.The biocompatibility and bioactivity of hemodialysis membranes:their impact in end-stage renal disease[J].Journal of Artificial Organs, 2019,22:14-28.
[33]Walker RJ,Sutherland WH,De Jong SA.Effect of changing from a cellulose acetate to a polysulphone dialysis membrane on protein oxidation and inflammation markers.Clin Nephrol.2004,61:198-206.
[34]Vincenzo Sepe,Marilena Gregorini,Teresa Rampino,et al.Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging[J].BMC Nephrology,2019,20:412.
